Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $100.77M June 30, 2015
Broadfin Capital 9.15M $69.18M Dec. 31, 2014
FMR 5.24M $39.11M June 30, 2015
STATE STREET CORPORATION 4.94M $36.86M June 30, 2015
Baker Bros. Advisors 4.35M $26.02M March 31, 2015
Royce & Associates 3.22M $24.04M June 30, 2015
BlackRock Fund Advisors 2.74M $20.44M June 30, 2015
Tudor Investment Corporation 2.39M $17.81M June 30, 2015
Vanguard 2.27M $16.91M June 30, 2015
BlackRock Institutional Trust Company, N.A. 2.03M $15.17M June 30, 2015
Wellington Management Company 1.65M $12.30M June 30, 2015
Highland Capital Management 1.59M $8.25M Sept. 30, 2014
Deerfield Management Company 1.35M $4.02M Dec. 31, 2012
Tiger Management 1.29M $9.74M Dec. 31, 2014
Oxford Asset Management 1.16M $8.68M June 30, 2015
MORGAN STANLEY 1.14M $5.70M Sept. 30, 2013

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors Dec. 31, 2010 1.17M $6.38M